Novartis

Welcome to the 'Novartis' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Novartis'.

Latest blogosphere posts tagged “Novartis”

• Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer

  
  Xconomy — Authority: 708
  Biotech , cancer , Drugs Luke Timmerman wrote: Prostate cancer has been one of the hot fields for new biotech drug development this year, and now Cambridge, MA-based Tokai Pharmaceuticals is getting into the game with a drug that it hopes will someday help men live longer and push the boundaries of ...
  3 hours ago

• (RX) Big Pharma and Biotech – Industry Outlook

  
  Stock Blog Hub — Authority: 506
  The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts. The next five years are expected to reflect a significant imbalance between new product introductions and patent ...
  15 hours ago

• (HGSI) Human Genome Sciences Reports Lower Q3 Loss

  
  Stock Blog Hub — Authority: 506
  Human Genome Sciences, Inc. ( HGSI ) reported third quarter net loss of $49 million or 32 cents per share, in-line with the Zacks Consensus Estimate. The company reported a net loss of $74.2 million or 50 cents in the year ago quarter. The lower net loss for the quarter was primarily attributable to increased ...
  2 days ago

• Whats Your Push Into China?

  
  The Global Small Business Blog — Authority: 126
  If you run a global small business, and I am assuming many of you do, what should you be doing to swing open that door to China? The first step is to track what others are doing and determine success rates. For example, innovative healthcare product company Novartis announced on Tuesday that it will spend U.S. $1 ...
  4 days ago

• Roche’s Korean Office Raided Over Tamiflu

  
  Pharmalot — Authority: 589
  Prosecutors have raided the Seoul office of Roche on suspicions the Swiss drugmaker illegally provided Tamiflu to HSBC and Novartis amid fears of a widespread outbreak of swine flu, The Financial Times reports. The South Korean Food and Drug Administration confirmed that prosecutors searched Roche’s office as part ...
  4 days ago

• Build it Boldly, and Pharma Will Come—and More Wisdom from Boston’s Biotech and Pharma Elite at Xconomy Forum

  
  Xconomy — Authority: 708
  Life Sciences , innovation , Xconomy Forum Ryan McBride wrote: It was an inspiring afternoon yesterday at Xconomy’s latest event, “Pharma’s Bet on Boston Innovation,” in Cambridge, MA. Local industry pioneers such as Millennium CEO Deborah Dunsire and Sirtris CEO Christoph Westphal talked about ...
  4 days ago

• Novartis buys into Chinese vaccine maker

  
  GenevaLunch — Authority: 448
  Novartis on the Rhine, at Basel © Novartis AG Basel, Switzerland (GenevaLunch) - Swiss drugs maker, Novartis, has acquired 85 percent of Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co. for $125 million, subject to government approval, the company announced 4 November. Tianyuan is a privately held ...
  5 days ago

• Novartis is making a multipronged push into China

  
  DailyFinance — Authority: 790
  Filed under: Company News , Investing , Healthcare , GlaxoSmithKline , Novartis Ever since China loosened its trade restrictions with the West, companies have jumped head-first into the Communist-run state, hoping to capitalize on selling products to the planets most populous nation. Pharmaceutical companies ...
  5 days ago

• Swine Flu Vaccine Close To Reality According to Experts

  
  Health Tips — Authority: 122
  Officials of the Federal government believe that the swine flu vaccine that would protect all Americans from future H1N1 outbreaks would be available by January or late November at the earliest. HoTop of Form wever, countries outside the United States and…
  5 days ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 589
  Hello, everyone. The middle of the week is upon us and that means one thing - meetings, deadlines and more projects to tackle. We relate. This calls for another cup of stimulation - and a water bottle, we are two-fisted drinkers, after all. And to help you cope, here are a few items of note. Have a good day… ...
  6 days ago

• Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News

  
  Xconomy — Authority: 708
  Roundup , Life Sciences , VC Rebecca Zacks wrote: A number of New England’s life sciences companies had good news to report this week. —Cambridge, MA-based Vertex Pharmaceuticals (NASDAQ: VRTX ) reported results from clinical trials that indicate its experimental hepatitis C drug, telaprevir, could ...
  6 days ago

• Novartis Pays $125 Million for Tianyuan Stake

  
  DealBook — Authority: 782
  Novartis, the Swiss drug giant, said Wednesday it has agreed to cough up $125 million for an 85 percent stake in Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical.
  6 days ago

• Student Dissertation Launches San Diego Life Sciences Tools Company, Sirigen

  
  Xconomy — Authority: 708
  Life Sciences , Medical Diagnostics , Genetics Denise Gellene wrote: The work leading to Brent Gaylord’s dissertation on using light-emitting polymers to detect bits of DNA was more far more than an academic exercise. His initial paper , and the intellectual property that was subsequently generated, ...
  6 days ago

• On Trade and Living Standards

  
  Ohaiyo Business Magazine — Authority: 432
  One of my favorite commenters, Ajay, writes: Wow, when the chief economist at Businessweek is capable of writing a sentence like "if U.S.-based companies are doing their research and product development overseas and their production there as well, its tough to see how ordinary workers in the U.S. will gain," its ...
  6 days ago

• Pharmalot… Pharmalittle… Morning Edition

  
  Pharmalot — Authority: 589
  Good morning, everyone. Nice to see you again. The sun is shining here on the Pharmalot corporate campus and we are busy bundling short people off to the school house. And like you, we will be focused on meetings and what-not, but will keep an eye out for interesting items to pass along. Here, in fact, are a few ...
  1 week ago

• Millions Die Due To High Prices For Malaria Drugs

  
  Pharmalot — Authority: 589
  Nearly a million people die from malaria each year because they can’t afford the most effective treatment and instead often buy old drugs to which the malaria parasite has become resistant, according to a study of six high-risk nations by Populations Services International Malaria , Reuters writes. Artemisinin ...
  1 week ago

• Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs

  
  Xconomy — Authority: 708
  Biotech , VC , deals Luke Timmerman wrote: Pulmatrix , the Lexington, MA-based company working to stop infectious bugs from being absorbed into the lungs, has raised $30.2 million in a Series B venture round to advance its unorthodox method for treating and preventing respiratory diseases like flu, the ...
  1 week ago

• Switching immunosuppressants reduces cancer risk in kidney

  
  Science Blog - Science news straight from the source — Authority: 617
  Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology
  1 week ago

• Cequent Pharmaceuticals, With First Oral RNAi Drug Soon to Enter Humans, Raises $3.4M

  
  Xconomy — Authority: 708
  Biotech , RNA Interference , VC Luke Timmerman wrote: [ Update: 7:15 pm Eastern, 10/30/09 ] Cambridge, MA-based Cequent Pharmaceuticals , one of the many aspiring firms in the field of RNA interference drug technology, has raised $3.35 million in equity in the first tranche of a venture round that ...
  1 week ago

• Obama Administration Launches Deceptive Swine Flu Propaganda Blitz To Counter Growing Criticism from Scientific and Medical Community By Richard Gale and Dr. Gary Null

  
  Creative-i — Authority: 147
  President Obama and his top health officials are engaging in a major public relations effort to divert attention away from whether its swine flu vaccine is effective and safe – to whether there is enough of it to go around. And the media, as always, is cooperating fully. This echoes the way media debate was ...
  1 week ago

Comments about Novartis